Medtronic has high hopes for U.S. launch of Endeavor stent

05/3/2006 | Reuters

Medtronic's new drug-eluting stent, Endeavor, is expected to help triple the company's sales over the next five years after its U.S. launch in 2007, the head of the company's vascular business said. Analysts see difficulties if the company can't gain the rights to license a technique called "rapid exchange," which facilitates stent delivery into the body, but the company said it expects strong growth regardless of rights to rapid exchange.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr Statistician I (US/TB/00/0028/SL)
Santa Clara, CA
Food & Drug Associate
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA